Methods Postmenopausal women with breast cancer were randomly assigned to receive alendronate or placebo for 1 year within 3 months after withdrawal of tamoxifen therapy <a href=https://nolvadex.mom>tamoxifen versus raloxifene</a>

Methods Postmenopausal women with breast cancer were randomly assigned to receive alendronate or placebo for 1 year within 3 months after withdrawal of tamoxifen therapy <a href=https://nolvadex.mom>tamoxifen versus raloxifene</a>